Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00582_DB00615_nanopub.RA6ZlkcXmIW-W7s4Xy2G8Qr7sWgwB1q_CXv4f5NhZ4ACA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00582_DB00615 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB00615 label "DDI between Voriconazole and Rifabutin - Rifabutin may decrease the serum concentration of voriconazole likely by increasing its metabolism via CYP3A enzymes. Voriconazole may increase the serum concentration of rifabutin likely by inhibiting its metabolism via CYP3A. Concomitant therapy is contraindicated. [drugbank_resource:DB00582_DB00615]" assertion.
- drugbank_resource:DB00582_DB00615 identifier "drugbank_resource:DB00582_DB00615" assertion.
- drugbank_resource:DB00582_DB00615 title "DDI between Voriconazole and Rifabutin - Rifabutin may decrease the serum concentration of voriconazole likely by increasing its metabolism via CYP3A enzymes. Voriconazole may increase the serum concentration of rifabutin likely by inhibiting its metabolism via CYP3A. Concomitant therapy is contraindicated." assertion.
- drugbank:DB00582 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB00615 assertion.
- drugbank:DB00615 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB00615 assertion.